Similar to This
Previous
List of Covid jab side effects that mean seek urgent medical help: UKHSA has explained which vaccines may be offered
getsurrey.co.uk/news/health/full-list-covid-jab-side-34805474

Open letter to Merz: Pfizer criticizes the federal government and reconsiders investments
n-tv.de/wirtschaft/Pfizer-kritisiert-Bundesregierung-und-ueberdenkt-Investitionen-id30951367.html

Key FactsPfizer Reconsiders Investments Amid Health Policy Shift
Jun 10, 2026 · Reading time: ~45 sec.
Summary created with AI assistance · Source: zeit.de
Summary created with AI assistance · Source: zeit.de
- Pfizer plans to cut investments in Germany due to altered pricing and market conditions.
- CEO Albert Bourla withdrew from the government’s Invest in Germany Summit scheduled for autumn.
- The company criticizes the government’s health policy for undermining investment predictability.
- Eli Lilly and Boehringer Ingelheim have already reduced investments following government austerity measures.
After careful consideration, I regret to inform you that I will not be able to participate on this occasion.— Albert Bourla, CEO of Pfizer, in a letter to German Chancellor Friedrich Merz regarding the Invest in Germany Summit; context: Pfizer is reevaluating investments in Germany amid the government's health policy.
Pfizer CEO warns German investment at risk over drug pricing policies: Pfizer is reviewing the timing and scope of planned investments in Germany ...
reuters.com/world/pfizer-ceo-warns-german-investment-risk-over-drug-pricing-policies-2026-06-10/

Metsera deal: Pfizer completes billion-dollar takeover: Metsera shareholders have given the green light for the multi-billion dollar takeover by the ...
wiwo.de/unternehmen/industrie/metsera-deal-pfizer-schliesst-milliardenschwere-uebernahme-ab/100174549.html

CEOs of Wells Fargo and Pfizer caution the U.S. could lose its edge to China without innovation
cnbc.com/2025/10/15/wells-fargo-pfizer-ceos-china-innovation.html

Greek CEO of Pfizer, Albert Bourla, Signs Deal With Trump to Lower Drug Prices - GreekReporter.com
greekreporter.com/2025/10/01/greek-ceo-pfizer-albert-bourla-deal-trump-lower-drug-prices/

President announces TrumpRx website for drugs, and pricing deal with Pfizer: The Trump administration says it is making deals with drug companies to lower prices ...
npr.org/sections/shots-health-news/2025/09/30/nx-s1-5558432/drug-prices-trumprx-pfizer

U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on China: Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are ...
nytimes.com/2025/09/10/business/trump-medicines-china-biotech.html

Trump "worthy of the Nobel Peace Prize" for COVID vaccines, Pfizer CEO says: Pfizer's CEO defended the safety and efficacy of its COVID vaccine and touted ...
axios.com/2025/09/03/covid-vaccine-trump-nobel-peace-prize-pfizer

Paid articlePaywallPfizer CEO Floats ‘Warp Speed’ Nobel Prize for Trump — as RFK Slashes Vaccine Research
mediaite.com/media/news/pfizer-ceo-floats-warp-speed-nobel-prize-for-trump-as-rfk-slashes-vaccine-research/

RFK Jr. cancels $500M in funding for mRNA vaccine development: The Department of Health and Human Services plans to cancel contracts and pull funding for some ...
apnews.com/article/kennedy-vaccines-mrna-pfizer-moderna-1fb5b9436f2957075064c18a6cbbe3c9

"Pfizergate": Important text messages from Ursula von der Leyen have been deleted
heise.de/news/Pfizergate-Die-verschwundenen-SMS-der-EU-Kommissionspraesidentin-10509151.html

Key FactsDeleted Texts Obscure Covid Vaccine Negotiations
Aug 4, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: heise.de
Summary created with AI assistance · Source: heise.de
- The EU Commission continues to withhold SMS exchanges between Ursula von der Leyen and Pfizer CEO Albert Bourla during vaccine talks.
- Von der Leyen’s chief of staff decided in 2021 not to archive the messages, considering them mere scheduling notes.
- The texts were deleted after multiple phone replacements and data were not transferred or recoverable.
- The controversy centers on a spring 2021 contract for up to 1.8 billion Covid-19 vaccine doses worth 35 billion euros.
The Commission must provide 'credible explanations that allow the public and the court to understand why these documents are not retrievable'— Judges of the European Court in their ruling from May 2025, addressing the transparency obligations of the EU Commission.
Pfizer CEO attending $25 million fundraiser at Trump's golf club after president demands drug price cuts, sources say
cbsnews.com/news/pfizer-ceo-albert-bourla-trump-golf-club-drug-price-cuts-sources-say/
No drug price pledges by Pfizer, others in talks with US government, Pfizer CEO says
reuters.com/business/healthcare-pharmaceuticals/pfizer-ceo-says-no-commitments-made-meetings-with-us-governments-drug-pricing-2025-06-09/

Pfizer CEO: HHS claims of ‘concealed safety concerns’ on mRNA vaccines are ‘completely inaccurate’
cnn.com/2025/05/30/health/pfizer-bourla-vaccines

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
cnbc.com/2025/04/29/pfizer-ceo-trump-tariff-uncertainty-is-deterring-us-investment.html

Pfizer taps Vanguard veteran for board amid fight with Starboard: Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest ...
reut.rs/3A0s29C
Starboard plotted a campaign against Pfizer’s chief. Then a blank email dropped in his inbox
ft.com/content/2c9bfa53-9c58-4d29-b98d-73ac636443be

Pfizer to double weekly U.S. output of vaccine in next few weeks - CEO: Pfizer Inc Chief Executive Albert Bourla said on Friday that the drugmaker expects to be ...
reuters.com/article/us-health-coronavirus-usa-pfizer-doses-idUSKBN2AJ2F8

Key FactsPfizer Set to Double Weekly COVID-19 Vaccine Output
Feb 20, 2021 · Reading time: ~45 sec.
Summary created with AI assistance · Source: reuters.com
Summary created with AI assistance · Source: reuters.com
- Pfizer expects to increase weekly vaccine shipments to the U.S. from 5 million to more than 10 million doses within weeks.
- Process enhancements have doubled batch sizes and shortened production time from 110 days to 60 days.
- As of February 17, 40 million vaccine doses had been delivered in the United States.
- The company agreed to supply 300 million doses by July end and is exploring ways to accelerate output further.
We have improved our processes to double the batch size and increase yield and we have deployed more efficient lab test methods to reduce release times,— Albert Bourla, Pfizer CEO, in remarks after President Joe Biden toured Pfizer's Michigan vaccine manufacturing facility
Next